The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(8-(4-morpholinophenylamino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl)isoindolin-1-one ID: ALA1956682
PubChem CID: 57345529
Max Phase: Preclinical
Molecular Formula: C23H21N7O2
Molecular Weight: 427.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1NCc2cc(-c3cnc(Nc4ccc(N5CCOCC5)cc4)c4ncnn34)ccc21
Standard InChI: InChI=1S/C23H21N7O2/c31-23-19-6-1-15(11-16(19)12-25-23)20-13-24-21(22-26-14-27-30(20)22)28-17-2-4-18(5-3-17)29-7-9-32-10-8-29/h1-6,11,13-14H,7-10,12H2,(H,24,28)(H,25,31)
Standard InChI Key: ZDLDULHTZCUMMG-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 37 0 0 0 0 0 0 0 0999 V2000
1.4773 -1.7808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1950 -1.3668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1921 -0.5347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4755 -0.1249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7612 -1.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7625 -0.5368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0268 -0.2791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5160 -0.9502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0289 -1.6225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4771 -2.6073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1871 -3.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1839 -3.8390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8932 -4.2494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6046 -3.8397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6025 -3.0153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8927 -2.6086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3207 -4.2524 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3187 -5.0762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0305 -5.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7484 -5.0786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7498 -4.2511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0333 -3.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4737 0.7015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1876 1.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7518 1.9312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7568 1.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4690 2.3504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1864 1.9362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8021 2.4905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4651 3.2474 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6413 3.1607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0883 3.7749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
15 16 2 0
16 11 1 0
6 7 1 0
14 17 1 0
17 18 1 0
7 8 2 0
8 9 1 0
9 5 2 0
4 6 1 0
1 10 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
5 6 1 0
4 23 1 0
10 11 1 0
23 24 2 0
24 28 1 0
1 2 2 0
27 25 1 0
11 12 2 0
25 26 2 0
26 23 1 0
27 28 2 0
5 1 1 0
12 13 1 0
2 3 1 0
13 14 2 0
28 29 1 0
29 30 1 0
30 31 1 0
31 27 1 0
14 15 1 0
31 32 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 427.47Molecular Weight (Monoisotopic): 427.1757AlogP: 2.61#Rotatable Bonds: 4Polar Surface Area: 96.68Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.24CX Basic pKa: 2.37CX LogP: 2.26CX LogD: 2.26Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.52Np Likeness Score: -1.37
References 1. Andrews MJ, Clase JA, Bar G, Tricarico G, Edwards PJ, Brys R, Chambers M, Schmidt W, MacLeod A, Hirst K, Allen V, Birault V, Le J, Harris J, Self A, Nash K, Dixon G.. (2012) Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis., 22 (6): [PMID:22342143 ] [10.1016/j.bmcl.2012.01.077 ]